-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Theriva Biologics, Inc. annual/quarterly Return On Equity history and growth rate from Q3 2014 to Q4 2022.
- Theriva Biologics, Inc. Return On Equity for the quarter ending December 31, 2022 was -33 %, a 65.8% decline year-over-year.
- Theriva Biologics, Inc. annual Return On Equity for 2023 was -42.9 %, a 30% decline from 2022.
- Theriva Biologics, Inc. annual Return On Equity for 2022 was -33 %, a 65.8% decline from 2021.
- Theriva Biologics, Inc. annual Return On Equity for 2021 was -19.9 %, a 113% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)